Page 119 - NobleCon19revC2_Neat

Inspire Veterinary Partners, Inc.

SELECTED FINANCIAL ITEMS IVP

(in millions of USD)
CQ4 '22 CQ1 '23 CQ2 '23 CQ3 '23 LTM
Income Statement Key Items
Total Revenue 3.18 4.28 4.49 4.12 16.07
Gross Profit 0.64 1.10 1.26 1.06 4.05
Gross Margin 20% 26% 28% 26% 25%
EBIT (1.14) (1.00) (0.93) (2.82) (5.90)
EBIT Margin -36% -23% -21% -68% -37%
Net Income to Common Shareholders (1.93) (1.54) (1.23) (7.88) (12.58)
Net Margin -61% -36% -27% -191% -78%

Balance Sheet Key Items
Total Assets 20.19 20.05 20.02 21.30 21.30
Cash & Short Term Investments 0.44 0.59 0.86 1.96 1.96
% of Assets 2% 3% 4% 9% 9%
Current Assets -Total 1.74 1.88 2.05 3.54 3.54
% of Assets 9% 9% 10% 17% 17%
Total Liabilities 25.32 26.73 27.92 18.58 18.58
% of Assets 125% 133% 139% 87% 87%
Current Liabilities - Total 7.25 8.32 9.81 5.09 5.09
% of Assets 36% 41% 49% 24% 24%
Long Term Debt 17.41 17.80 17.53 12.92 12.92
% of Assets 86% 89% 88% 61% 61%
Total Equity (5.14) (6.67) (7.90) 2.71 2.71
% of Assets -25% -33% -39% 13% 13%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (0.34) (0.31) (0.20) (2.56) (3.41)
Net Cash Flow - Investing (5.68) (0.01) (0.11) (0.24) (6.04)
Net Cash Flow - Financing 6.29 0.47 0.58 3.89 11.23

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference